Johnson & Johnson At 52-Week Lows: Is It Attractive?
Johnson & Johnson is well-prepared to weather a potential recession. See why I believe JNJ stock is an attractive low-risk pick in the current environment.
Intel Drops The Dividend Bombshell
Intel Corporation cut its dividend by two-thirds. The writing was on the wall due to INTC's cash flow problems. Click here for my take on INTC's action.
British American Tobacco Vs. Philip Morris: One's Way Better
The current environment makes tobacco companies look interesting, as tobacco companies tend to do well during recessions. See which one's better in BTI vs. PM.
Is AbbVie A Buy Following The Share Price Slump?
AbbVie has seen its shares pull back by close to 20% over the last couple of weeks. Read more to see if this makes ABBV stock a buy.
Energy Transfer's Dividend: Mission Accomplished
Energy Transfer is relatively inexpensive and offers a high and well-covered dividend. Click here to read why ET stock is still attractively priced.
Exxon Mobil Vs. Chevron: One's Way Better
Exxon Mobil (XOM) and Chevron (CVX) benefit from tight oil markets. Find out which one is a better pick.
Altria Vs. Philip Morris: One's Way Better
Phillip Morris and Altria should continue to do well during a harsh environment in 2023 on an operational basis. Read more here.
BAM Is Misunderstood And Offers A Great Opportunity
Brookfield Asset Management is an attractive asset management pure-play with compelling growth potential. See why we recommend BAM a buy.
Stonk Broker Live News